Search

everythinglearnresearchcommunity

for

Search:↓

Some natural compounds from Iris plants can block enzymes related to certain disorders, with a few affecting both targeted enzymes.

Enzymes are classified into six types and are essential for many biological processes, with only a few targeted by drugs.

The research found that specific stem cells maintain skin gland openings and that disrupting their activity can cause blockages or early cancer signs, indicating a need for targeted treatments.

Alopecia areata is a hair loss disease caused by complex immune reactions, and new targeted treatments show promise.

Skin fat has important roles in hair growth, skin repair, immune defense, and aging, and could be targeted for skin and hair treatments.

EGFR helps protect hair follicles from bacterial infections.

Ritlecitinib effectively regrows hair in severe alopecia areata and is well tolerated.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

A new treatment using a DNA aptamer can promote hair growth by targeting a specific receptor.

Antibody drug conjugates show promise in targeting cancer cells while reducing harm to healthy cells.

Multiple treatments work best for hair loss.

Lipid nanoparticles improve treatment delivery and are key to future therapies, but challenges in manufacturing and safety remain.

Activating the GDNF-GFRα1-RET signaling pathway could potentially promote skin and limb regeneration in humans and could be used to treat hair loss and promote wound healing.

Spanlastics improve drug delivery by enhancing bioavailability and targeting, reducing side effects.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

EGFR inhibitors can cause skin issues, but managing them is important for treatment success.

Alopecia areata patients have higher levels of certain immune receptors, suggesting new treatment possibilities.

Classifying alopecia helps diagnose and treat different types of hair loss accurately.

A new engineered treatment shows promise in curing heart fibrosis.

Ablative CO2 laser resurfacing tightens skin by destroying and regenerating skin layers.

Scaffold-based drug delivery systems improve oral cancer treatment by targeting drugs directly to cancer cells, reducing side effects.

Antioxidant nanoparticles show promise for treating inflammatory diseases but need more research for safe and effective use.

Different compounds move through artificial sebum at different rates, which can help choose the best ones for targeting hair follicles.

A SALT score of ≤ 20 indicates meaningful improvement in alopecia areata treatment.

Certain microRNAs may help treat alopecia areata by targeting immune pathways.

EDA2R is a key gene linked to ageing and diseases, and targeting it may help treat conditions like hair loss and chronic diseases.

Porokeratosis should be considered for scalp lesions, with new treatments like topical cholesterol/lovastatin offering promise.

Biodegradable polymers can improve cannabinoid delivery but need more clinical trials.

High-dose testosterone with finasteride improves muscle health in males with spinal cord injury.

Vaccines and targeting TrxR variants can help prevent cancer and reduce metastasis.